Global Advanced Visualization Systems Market 2017-2021

SKU ID :TNV-11016279 | Published Date: 22-Aug-2017 | No. of pages: 139
Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Advanced CT visualization systems • Advanced MRI visualization systems • Advanced X-ray visualization systems • Advanced ultrasound visualization systems • Advanced PET visualization systems • Advanced SPECT visualization systems • Advanced endoscope visualization systems PART 07: Market segmentation by application • Cardiology • Oncology • Orthopedic and neurology • Gastroenterology and urology PART 08: Market segmentation by end-user • Hospitals and clinics • ASCs • Diagnostic centers PART 09: Geographical segmentation • Advanced visualization systems market in Americas • Advanced visualization systems market in EMEA • Advanced visualization systems market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Market challenges PART 12: Market trends • Focus on development of ultra-portable and wearable systems • Integration of robotic surgical platform and hybrid operating room equipment • Increase in funding PART 13: Vendor landscape • Competitive landscape PART 14: Key vendor analysis • GE Healthcare • Olympus • Philips Healthcare • Siemens Healthineers • Toshiba Medical Systems • Key companies to watch • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Overview of software platforms used in advanced visualization systems Exhibit 02: Healthcare cloud and need for big data analytics Exhibit 03: Market overview: Global advanced visualization systems market (based on product and application) 2017 Exhibit 04: Global advanced visualization systems market 2017-2021 ($ billions) Exhibit 05: Product launches in global interventional image-guided systems market Exhibit 06: Five forces analysis Exhibit 07: Global advanced visualization systems market by product 2016 and 2021 ($ billions) Exhibit 08: Advanced visualization system product details Exhibit 09: Market overview: Advanced CT visualization systems Exhibit 10: Global advanced CT visualization systems market 2016-2021 ($ billions) Exhibit 11: Game changing strategies of companies to penetrate the market Exhibit 12: Market overview: Advanced MRI visualization systems Exhibit 13: Global advanced MRI visualization systems market 2016-2021 ($ billions) Exhibit 14: Global advanced X-ray visualization systems market 2016-2021 ($ millions) Exhibit 15: Market overview: Advanced ultrasound visualization systems Exhibit 16: Global advanced ultrasound visualization systems market 2016-2021 ($ millions) Exhibit 17: Market overview: Advanced PET visualization systems Exhibit 18: Global advanced PET visualization systems market 2016-2021 ($ millions) Exhibit 19: Market overview: Advanced SPECT visualization systems Exhibit 20: Global advanced SPECT visualization systems market 2016-2021 ($ millions) Exhibit 21: Global advanced endoscope visualization systems market 2016-2021 ($ millions) Exhibit 22: Global advanced visualization systems market by application 2016 Exhibit 23: Market overview: Advanced visualization systems for cardiology Exhibit 24: Few important technology and system integration factors Exhibit 25: Market overview: Advanced visualization systems for oncology Exhibit 26: Few important technology and system integration factors Exhibit 27: Market overview: Advanced visualization systems for orthopedic and neurology Exhibit 28: Game-changing strategies and market impact analysis Exhibit 29: Market overview: Advanced visualization systems for gastroenterology and urology Exhibit 30: Global advanced visualization systems market by end-users 2016 Exhibit 31: Factors impacting sales of advanced visualization systems Exhibit 32: Number of coronary angiography in few countries in Americas 2013 Exhibit 33: Projected new cancer cases and incidence rates in US 2014-2021 Exhibit 34: Market overview: Advanced visualization systems market in Americas Exhibit 35: Advanced visualization systems market in Americas 2016-2021 ($ billions) Exhibit 36: Advanced visualization systems market in Americas: Market analysis in various countries Exhibit 37: Market overview: Advanced visualization systems market in US Exhibit 38: Market overview: Advanced visualization systems market in EMEA Exhibit 39: Percentage of women screened for mammography and survival rate of women with breast cancer in 2013 (based on OECD 2015) Exhibit 40: Advanced visualization systems market in EMEA 2016-2021 ($ billions) Exhibit 41: Advanced visualization systems market in EMEA: Market analysis in various countries Exhibit 42: Market overview: Advanced visualization systems market in UK Exhibit 43: Market overview: Advanced visualization systems market in APAC Exhibit 44: Advanced visualization systems market in APAC 2016-2021 ($ millions) Exhibit 45: Advanced visualization systems market in APAC: Market analysis in various countries Exhibit 46: Novel technologies in advanced hybrid imaging systems Exhibit 47: Fall and hip fracture cases in US in 2016 Exhibit 48: Number of road injuries in UK in 2015 Exhibit 49: Physician payment by Medicare for cardiology procedure Exhibit 50: Comparison between diagnostic and image-guided MRI procedures Exhibit 51: Number of hospitals merged and acquired between 2010 to 2015 in US Exhibit 52: Competitive structure analysis of global advanced visualization systems market Exhibit 53: Competitive landscape analysis of global advanced visualization systems market 2016 Exhibit 54: GE Healthcare: Strength assessment Exhibit 55: GE Healthcare: Strategy assessment Exhibit 56: GE Healthcare: Opportunity assessment Exhibit 57: Olympus: Strength assessment Exhibit 58: Olympus: Strategy assessment Exhibit 59: Olympus: Opportunity assessment Exhibit 60: Philips Healthcare: Strength assessment Exhibit 61: Philips Healthcare: Strategy assessment Exhibit 62: Philips Healthcare: Opportunity assessment Exhibit 63: Siemens Healthineers: Strength assessment Exhibit 64: Siemens Healthineers: Strategy assessment Exhibit 65: Siemens Healthineers: Opportunity assessment Exhibit 66: Toshiba Medical Systems: Strength assessment Exhibit 67: Toshiba Medical Systems: Strategy assessment Exhibit 68: Toshiba Medical Systems: Opportunity assessment Exhibit 69: Key companies to watch in global advanced visualization systems market Exhibit 70: Other prominent vendors
GE Healthcare, Olympus, Philips Healthcare, Siemens Heathineers, Toshiba Medical Systems, Accuray, Accutome, ALPINION MEDICAL SYSTEMS, Analogic Corporation, ASAHIROENTGEN, BenQ Medical Technology, Shenzhen Bestman Instrument, BMV Technology, Brain Biosciences, Brainlab, Bruker, Capintec, Cephasonics, CHISON, Clear Guide Medical, CMR Naviscan Corporation, ContextVision, CurveBeam, CYMO, DDD-Diagnostic, Delphinus Medical Technologies, Ecare, Elekta, EOS imaging, Esaote, Evena Medical, Fuel 3D Technologies, Gendex, GlobelMed, Guangzhou Yueshen Medical Equipment, Healcerion, Hologic, Imaging Sciences International, INSIGHTEC, Intelerad Medical Systems, INTRASENSE, J. Morita, Konica Minolta, Koning, Lumendi, MedGyn, Median Technologies, Mediso, Mindray, Mobisante, MRI Interventions, NanoVibronix, NeuroLogica, NeuSoft, OrthoScan, Pie Medical Imaging, PLANMECA OY, Samsung Medison, Shimadzu, Dentsply Sirona, Shanghai United Imaging Healthcare, SonoStar, Sofie Biosciences, SOREDEX, St. Jude Medical, SurgicEye, Terumo Medical Corporation, TOMTEC IMAGING SYSTEMS, Trivitron Healthcare, Wuhan Tianyi Electronic, Xoran Technologies, and Ziehm Imaging.
  • PRICE
  • $2500
    $4000

Our Clients